By Admin at 13 Jul 2016
A new study showed that incorporating immunotherapy into ovarian cancer treatment might combat chemotherapy resistance and improve survival rates.
58
Current Gateway-funded clinical trials
150+
Clinical trials funded at leading institutions worldwide
$16.56
Funds one patient for one day at a Gateway-funded clinical trial
